why choose us

First received: December 06, 2022

Clinical Trial: A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

Study Status: Completed

Recruit Status: RECRUITING

Condition: Uveitic Macular Edema

Study Type: INTERVENTIONAL


Official Title: A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patie

Brief Summary: This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.

Read more